Central Trust Company’s Celgene Corp CELG Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q4 | – | Sell |
-68,399
| Closed | -$6.79M | – | 1251 |
|
|
2019
Q3 | $6.79M | Sell |
68,399
-1,956
| -3% | -$186K | 0.38% | 61 |
|
|
2019
Q2 | $6.5M | Sell |
70,355
-7,273
| -9% | -$691K | 0.37% | 65 |
|
|
2019
Q1 | $7.32M | Sell |
77,628
-23,435
| -23% | -$2.05M | 0.44% | 55 |
|
|
2018
Q4 | $6.48M | Sell |
101,063
-1,930
| -2% | -$142K | 0.43% | 55 |
|
|
2018
Q3 | $9.22M | Buy |
102,993
+1,607
| +2% | +$142K | 0.54% | 44 |
|
|
2018
Q2 | $8.05M | Sell |
101,386
-1,909
| -2% | -$159K | 0.51% | 44 |
|
|
2018
Q1 | $9.21M | Sell |
103,295
-3,535
| -3% | -$339K | 0.59% | 41 |
|
|
2017
Q4 | $11.1M | Sell |
106,830
-5,146
| -5% | -$581K | 0.68% | 34 |
|
|
2017
Q3 | $16.3M | Buy |
111,976
+3,358
| +3% | +$457K | 1.06% | 24 |
|
|
2017
Q2 | $14.1M | Buy |
108,618
+7,393
| +7% | +$906K | 0.93% | 28 |
|
|
2017
Q1 | $12.6M | Buy |
101,225
+1,071
| +1% | +$128K | 0.84% | 31 |
|
|
2016
Q4 | $11.6M | Sell |
100,154
-2,004
| -2% | -$223K | 0.8% | 32 |
|
|
2016
Q3 | $10.7M | Buy |
102,158
+5,963
| +6% | +$645K | 0.78% | 27 |
|
|
2016
Q2 | $9.49M | Sell |
96,195
-831
| -0.9% | -$86K | 0.71% | 35 |
|
|
2016
Q1 | $9.71M | Buy |
97,026
+4,215
| +5% | +$434K | 0.77% | 31 |
|
|
2015
Q4 | $11.1M | Buy |
92,811
+1,945
| +2% | +$225K | 0.92% | 24 |
|
|
2015
Q3 | $9.83M | Buy |
90,866
+278
| +0.3% | +$34.5K | 0.86% | 26 |
|
|
2015
Q2 | $10.5M | Sell |
90,588
-5,050
| -5% | -$577K | 0.82% | 28 |
|
|
2015
Q1 | $11M | Sell |
95,638
-682
| -0.7% | -$81.5K | 0.89% | 27 |
|
|
2014
Q4 | $10.8M | Sell |
96,320
-4,690
| -5% | -$495K | 0.88% | 27 |
|
|
2014
Q3 | $9.57M | Sell |
101,010
-3,661
| -3% | -$330K | 0.76% | 28 |
|
|
2014
Q2 | $8.99M | Buy |
104,671
+3,035
| +3% | +$231K | 0.71% | 31 |
|
|
2014
Q1 | $7.09M | Buy |
101,636
+2,566
| +3% | +$203K | 0.59% | 37 |
|
|
2013
Q4 | $8.37M | Buy |
99,070
+7,030
| +8% | +$556K | 0.7% | 33 |
|
|
2013
Q3 | $7.09M | Buy |
92,040
+4,224
| +5% | +$296K | 0.64% | 40 |
|
|
2013
Q2 | $5.14M | Buy |
+87,816
| New | +$5.28M | 0.49% | 53 |
|
Other funds holding CELG
FP
HCM
PCMC
WCG
Central Trust Company's CELG Position: Q4 2019 in Review
Central Trust Company sold out of Celgene Corp (CELG) in Q4 2019, closing a stake of 68,399 shares — an estimated $6.79M sold.
Central Trust Company first reported a position in CELG in Q2 2013 and held it in 26 quarters. The position peaked at $16.3M in Q3 2017. 4 funds tracked by Wall St. Rank hold CELG as of Q4 2019.
- Central Trust Company reported no remaining Celgene Corp position as of Q4 2019 after selling out during the quarter.
- Central Trust Company sold 68,399 Celgene Corp shares in Q4 2019, an estimated $6.79M.
- Central Trust Company first reported a position in Celgene Corp in Q2 2013 and held it in 26 quarters.
- Central Trust Company's Celgene Corp position peaked at $16.3M in Q3 2017.
- 4 funds tracked by Wall St. Rank held Celgene Corp as of Q4 2019.
Based on Central Trust Company's 13F filing for Q4 2019, filed 21 Jan 2020.